SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer

NCT00270413 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: SU11248

Sponsor

Universitaire Ziekenhuizen KU Leuven

Collaborators

[object Object]